Market Overview:
The global Covid-19 vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Covid-19, rising awareness about preventive measures, and technological advancements in the field of vaccine development. The global Covid-19 vaccine market is segmented on the basis of type, application, and region. On the basis of type, it is divided into DNA vaccines, nonreplicating viral vector vaccines, protein subunit vaccines, RNA vaccines,, and others. Nonreplicating viral vector vaccines are further classified into adenovirus vectors and lentiviral vectors. On the basis of application,, it is segmented into adults and children. Adults are further classified into healthy individuals and high-risk groups such as elderly people or those with chronic diseases such as diabetes or heart disease). Geographically,, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany., U K.), Asia Pacific (China,. India,. Japan) Middle East & Africa(South Africa).
Product Definition:
Covid-19 vaccine is a vaccine that can help prevent infection with the SARS-CoV-2 virus, the cause of COVID-19. The vaccine is still in development and has not yet been licensed for use.
DNA:
DNA is the material that carries the genetic instructions used in the development of an organism (plants and animals). DNA plays a key role in Covid-19 research as it contains information about all previous infections experienced by an individual. This is because, apart from providing information related to past infections, DNA can also be used to develop effective vaccines for new viral diseases.
The use of recombinant DNA technology has led to significant advances in molecular biology and medicine over recent years.
Non-replicating Viral Vector:
Non-replicating viral vector is a type of vaccine that uses non-pathological viruses to deliver the body's immune response. Viral vectors have been used in various types of vaccines including DNA, RNA, and protein based vaccines. Currently, most of the commercially available vaccines use bacterial cells or yeast as viral carriers to produce antibodies against the targeted disease.
Application Insights:
Adults application segment accounted for the largest share of more than 60.0% in 2017. The large share is attributed to the growing number of adults population that has not been vaccinated so far against COVID-19. As per WHO, around 1/3rd of the global deaths occur due to vaccine-preventable diseases every year. Therefore, increasing awareness about immunization among adults and promoting them to get immunized is one of the major strategies adopted by various governments worldwide to reduce these mortality rates caused by Covid-19 infection in adults and children respectively.
The children application segment was valued over USD 200 million in 2017 owing to high incidence rate of Covid-19 infection in this age group as compared with other age groups globally (1). In addition, a rise in travel activities and migration patterns among parents are some other factors contributing towards significant growth rate for this segment during recent years (2).
Regional Analysis:
North America dominated the global market in 2017. The presence of a strong research base and advanced healthcare infrastructure are some of the major factors contributing to its growth. Furthermore, high awareness levels regarding COVID-19 infection and rapid adoption of novel therapeutics are expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing COVID-19 cases in emerging economies such as India and China. In addition, rising investments by governments for development of new vaccines is likely to boost revenue generation in this region over next eight years. For instance, Chinese government has allocated USD X million for strengthening public health system against Covid-19 from 2018 till 2023 (USD X million per year).
Growth Factors:
- Increasing global prevalence of Covid-19
- Government initiatives for vaccination programs
- Rising public awareness about the benefits of vaccination
- Growing demand for preventive healthcare measures
- Technological advancements in vaccine development
Scope Of The Report
Report Attributes
Report Details
Report Title
Covid-19 Vaccine Market Research Report
By Type
DNA, Non-replicating Viral Vector, Protein Subunit, RNA, Others
By Application
Adults, Children
By Companies
Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Covid-19 Vaccine Market Report Segments:
The global Covid-19 Vaccine market is segmented on the basis of:
Types
DNA, Non-replicating Viral Vector, Protein Subunit, RNA, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Moderna
- CanSino Biologicals
- Inovio Pharmaceuticals
- Shenzhen Geno-Immune Medical Institute
- GlaxoSmithKine
- Pfizer
- Johnson＆Johnson
- Heat Biologics
- Sanofi
Highlights of The Covid-19 Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA
- Non-replicating Viral Vector
- Protein Subunit
- RNA
- Others
- By Application:
- Adults
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Covid-19 Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Covid-19 is a vaccine that protects people from the Covid virus. The Covid virus is a type of respiratory infection that can cause severe illness in children and adults. The vaccine helps protect against this virus by helping to prevent its spread from person to person.
Some of the key players operating in the covid-19 vaccine market are Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics, Sanofi.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Covid-19 Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Covid-19 Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Covid-19 Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Covid-19 Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Covid-19 Vaccine Market Size & Forecast, 2020-2028
4.5.1 Covid-19 Vaccine Market Size and Y-o-Y Growth
4.5.2 Covid-19 Vaccine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DNA
5.2.2 Non-replicating Viral Vector
5.2.3 Protein Subunit
5.2.4 RNA
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Adults
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Covid-19 Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Covid-19 Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DNA
9.6.2 Non-replicating Viral Vector
9.6.3 Protein Subunit
9.6.4 RNA
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Adults
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DNA
10.6.2 Non-replicating Viral Vector
10.6.3 Protein Subunit
10.6.4 RNA
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Adults
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DNA
11.6.2 Non-replicating Viral Vector
11.6.3 Protein Subunit
11.6.4 RNA
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Adults
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DNA
12.6.2 Non-replicating Viral Vector
12.6.3 Protein Subunit
12.6.4 RNA
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Adults
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DNA
13.6.2 Non-replicating Viral Vector
13.6.3 Protein Subunit
13.6.4 RNA
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Adults
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Covid-19 Vaccine Market: Competitive Dashboard
14.2 Global Covid-19 Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Moderna
14.3.2 CanSino Biologicals
14.3.3 Inovio Pharmaceuticals
14.3.4 Shenzhen Geno-Immune Medical Institute
14.3.5 GlaxoSmithKine
14.3.6 Pfizer
14.3.7 Johnson＆Johnson
14.3.8 Heat Biologics
14.3.9 Sanofi
